IOBT
IO Biotech·NASDAQ
--
--(--)
--
--(--)
IOBT fundamentals
During Q3 2025, IO Biotech (IOBT) reported revenue of --, a YoY change of 0.00%. Net income was -8.38M, a YoY change of 65.11%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | TTM |
|---|
Start Date | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | -- |
End Date | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Cost of Revenue | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 3.43M -- | 2.54M -- | 3.81M -- | 8.98M -- | 7.04M +105.25% | 21.39M +742.65% | 17.01M +346.11% | 18.16M +102.17% | 15.87M +125.29% | 20.39M -4.70% | 17.92M +5.37% | 21.85M +20.32% | 23.48M +48.02% | 28.18M +38.23% | 20.20M +12.68% | 21.53M -1.46% | 26.50M +12.86% | 26.94M -4.40% | 22.58M +11.82% | 23.17M +7.60% | 19.36M -26.97% | 92.05M -- |
Selling, General and Administrative Expenses | 654.00K -- | 329.00K -- | 965.00K -- | 2.25M -- | 2.91M +345.57% | 4.96M +1406.08% | 6.70M +594.72% | 5.93M +164.01% | 5.84M +100.51% | 5.96M +20.20% | 6.02M -10.14% | 5.35M -9.89% | 5.83M -0.24% | 6.41M +7.67% | 5.89M -2.29% | 5.68M +6.30% | 6.33M +8.53% | 5.80M -9.62% | 6.21M +5.49% | 6.52M +14.65% | 5.61M -11.27% | 24.14M -- |
General and Administrative Expenses | -- -- | 1.68M -- | -- -- | -- -- | -- -- | 11.08M +559.25% | -- -- | -- -- | -- -- | 24.44M +120.52% | -- -- | -- -- | 5.83M -- | 6.41M -73.76% | 5.89M -- | 5.68M -- | 6.33M +8.53% | 5.80M -9.62% | 6.21M +5.49% | 6.52M +14.65% | 5.61M -11.27% | 24.14M -- |
Research and Development Expenses | 2.78M -- | 2.21M -- | 2.85M -- | 6.74M -- | 4.13M +48.65% | 16.44M +643.89% | 10.31M +261.87% | 12.23M +81.53% | 10.02M +142.78% | 14.43M -12.21% | 11.90M +15.47% | 16.50M +34.99% | 17.66M +76.16% | 21.77M +50.83% | 14.31M +20.26% | 15.85M -3.97% | 20.18M +14.29% | 21.15M -2.86% | 16.38M +14.42% | 16.65M +5.07% | 13.74M -31.90% | 67.92M -- |
Operating Income | -3.43M -- | -2.54M -- | -3.81M -- | -8.98M -- | -7.04M -105.25% | -21.39M -742.65% | -17.01M -346.11% | -18.16M -102.17% | -15.87M -125.29% | -20.39M +4.70% | -17.92M -5.37% | -21.85M -20.32% | -23.48M -48.02% | -28.18M -38.23% | -20.20M -12.68% | -21.53M +1.46% | -26.50M -12.86% | -26.94M +4.40% | -22.58M -11.82% | -23.17M -7.60% | -19.36M +26.97% | -92.05M -- |
Non-Operating Income (Loss) | -57.00K -- | -15.00K -- | 65.00K -- | -29.38M -- | 2.58M +4626.32% | 154.00K +1126.67% | -128.00K -296.92% | -230.00K +99.22% | 292.00K -88.68% | 1.30M +747.40% | 1.29M +1104.69% | 1.21M +624.35% | 1.37M +367.81% | 2.35M +80.38% | 1.16M -10.19% | 1.22M +1.24% | 2.70M +97.51% | -3.94M -267.59% | 309.00K -73.25% | -2.93M -339.89% | 9.31M +245.18% | 2.75M -- |
Gain (Loss) on Change in Fair Value | -- -- | -1.99M -- | -- -- | -- -- | -- -- | -26.54M -1236.78% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | -- -- | -2.59M -- | 9.85M -- | -- -- |
Gain (Loss) on Foreign Currency Exchange | -- -- | 114.00K -- | -- -- | -- -- | -- -- | 319.00K +179.82% | -- -- | -- -- | -- -- | 130.00K -59.25% | -- -- | -- -- | -342.00K -- | 405.00K +211.54% | -462.00K -- | -90.00K -- | 1.63M +576.61% | -4.67M -1252.35% | -105.00K +77.27% | -374.00K -315.56% | 98.00K -93.99% | -5.05M -- |
Other Non-Operating Income (Loss) | -50.00K -- | 1.87M -- | 137.00K -- | -29.30M -- | 2.65M +5394.00% | 26.52M +1320.51% | -20.00K -114.60% | -286.00K +99.02% | -87.00K -103.29% | 392.00K -98.52% | 258.00K +1390.00% | 10.00K +103.50% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Interest Expense | 7.00K -- | 11.00K -- | 72.00K -- | 71.00K -- | 67.00K +857.14% | 151.00K +1272.73% | 108.00K +50.00% | -56.00K -178.87% | -379.00K -665.67% | -783.00K -618.54% | -1.03M -1051.85% | -1.20M -2035.71% | -1.71M -350.66% | -1.95M -148.91% | -1.62M -57.30% | -1.31M -9.62% | -1.07M +37.47% | -722.00K +62.96% | -414.00K +74.40% | -32.00K +97.56% | 631.00K +159.08% | -537.00K -- |
Interest Expense | 7.00K -- | 11.00K -- | 72.00K -- | 71.00K -- | 67.00K +857.14% | 151.00K +1272.73% | 123.00K +70.83% | 102.00K +43.66% | 78.00K +16.42% | -3.00K -101.99% | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | -- -- | 253.00K -- | 886.00K -- | -- -- |
Interest Income | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 15.00K -- | 158.00K -- | 457.00K -- | 780.00K -- | 1.03M +6753.33% | 1.20M +656.96% | 1.71M +273.74% | 1.95M +149.87% | 1.62M +57.30% | 1.31M +9.62% | 1.07M -37.47% | 722.00K -62.96% | 414.00K -74.40% | 285.00K -78.26% | 255.00K -76.12% | 1.68M -- |
Pretax Income From Continuing Operations | -3.49M -- | -2.55M -- | -3.75M -- | -38.36M -- | -4.46M -27.92% | -21.24M -731.68% | -17.14M -357.26% | -18.39M +52.06% | -15.57M -249.01% | -19.08M +10.15% | -16.64M +2.92% | -20.65M -12.26% | -22.12M -42.03% | -25.83M -35.34% | -19.04M -14.45% | -20.31M +1.62% | -23.81M -7.63% | -30.89M -19.59% | -22.27M -16.98% | -26.10M -28.49% | -10.04M +57.82% | -89.30M -- |
Income Tax Expense | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | 68.00K -- | 66.00K -- | 104.00K -- | 115.00K -- | 987.00K +1351.47% | 406.00K +515.15% | 532.00K +411.54% | -439.00K -481.74% | 353.00K -64.24% | 415.00K +2.22% | 374.00K -29.70% | 209.00K +147.61% | 445.00K +26.06% | 146.00K -64.82% | 118.00K -68.45% | -1.66M -896.17% | -955.00K -- |
Current Income Tax | -- -- | 0 -- | -- -- | -- -- | -- -- | 155.00K -- | -- -- | -- -- | -- -- | 1.20M +672.26% | -- -- | -- -- | -- -- | 852.00K -28.82% | -- -- | -- -- | -- -- | 1.44M +69.37% | -- -- | -- -- | -- -- | -- -- |
Deferred Income Tax | -- -- | 0 -- | -- -- | -- -- | -- -- | -87.00K -- | -- -- | -- -- | -- -- | 76.00K +187.36% | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -3.49M -- | -2.55M -- | -3.75M -- | -38.36M -- | -4.46M -27.92% | -21.31M -734.34% | -17.20M -359.02% | -18.50M +51.78% | -15.69M -251.59% | -20.07M +5.81% | -17.04M +0.93% | -21.18M -14.51% | -21.68M -38.19% | -26.18M -30.45% | -19.46M -14.16% | -20.69M +2.32% | -24.02M -10.78% | -31.33M -19.67% | -22.42M -15.23% | -26.22M -26.74% | -8.38M +65.11% | -88.35M -- |
Net Income Attributable to Owners of the Company | -3.49M -- | -2.55M -- | -3.75M -- | -38.36M -- | -4.46M -27.92% | -21.31M -734.34% | -17.20M -359.02% | -18.50M +51.78% | -15.69M -251.59% | -20.07M +5.81% | -17.04M +0.93% | -21.18M -14.51% | -21.68M -38.19% | -26.18M -30.45% | -19.46M -14.16% | -20.69M +2.32% | -24.02M -10.78% | -31.33M -19.67% | -22.42M -15.23% | -26.22M -26.74% | -8.38M +65.11% | -88.35M -- |
Preferred Stock Dividends | 661.00K -- | 869.00K -- | 1.84M -- | 2.09M -- | 2.07M +213.62% | 1.10M +26.81% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income Attributable to Common Stockholders | -4.15M -- | -3.42M -- | -5.59M -- | -40.45M -- | -6.54M -57.51% | -22.41M -554.72% | -17.20M -207.93% | -18.50M +54.28% | -15.69M -140.06% | -20.07M +10.44% | -17.04M +0.93% | -21.18M -14.51% | -21.68M -38.19% | -26.18M -30.45% | -19.46M -14.16% | -20.69M +2.32% | -24.02M -10.78% | -31.33M -19.67% | -22.42M -15.23% | -26.22M -26.74% | -8.38M +65.11% | -88.35M -- |
Other Comprehensive Income | 248.00K -- | 177.00K -- | -1.77M -- | 1.19M -- | -681.00K -374.60% | -2.19M -1339.55% | -2.65M -49.89% | -4.38M -467.98% | -5.40M -692.95% | 3.77M +272.06% | 517.00K +119.53% | -141.00K +96.78% | -108.00K +98.00% | 204.00K -94.60% | 194.00K -62.48% | -151.00K -7.09% | -1.37M -1172.22% | 4.15M +1933.82% | 259.00K +33.51% | -220.00K -45.70% | -353.00K +74.31% | 3.83M -- |
Total Comprehensive Income | -3.24M -- | -2.38M -- | -5.51M -- | -37.17M -- | -5.14M -58.73% | -23.50M -888.77% | -19.85M -260.01% | -22.87M +38.46% | -21.09M -310.03% | -16.30M +30.66% | -16.53M +16.74% | -21.32M +6.80% | -21.79M -3.31% | -25.98M -59.41% | -19.26M -16.55% | -20.84M +2.26% | -25.39M -16.53% | -27.18M -4.64% | -22.16M -15.05% | -26.44M -26.88% | -8.73M +65.61% | -84.51M -- |
Total Comprehensive Income Attributable to Owners of the Company | -3.24M -- | -2.38M -- | -5.51M -- | -37.17M -- | -5.14M -58.73% | -23.50M -888.77% | -19.85M -260.01% | -22.87M +38.46% | -21.09M -310.03% | -16.30M +30.66% | -16.53M +16.74% | -21.32M +6.80% | -21.79M -3.31% | -25.98M -59.41% | -19.26M -16.55% | -20.84M +2.26% | -25.39M -16.53% | -27.18M -4.64% | -22.16M -15.05% | -26.44M -26.88% | -8.73M +65.61% | -84.51M -- |
Basic EPS | -23.41 -- | -- -- | -31.53 -- | -228.29 -- | -36.88 -57.54% | -0.78 -- | -0.6 +98.10% | -0.64 +99.72% | -0.54 +98.54% | -0.7 +10.26% | -0.59 +1.67% | -0.74 -15.62% | -0.43 +20.37% | -0.4 +42.86% | -0.3 +49.15% | -0.31 +58.11% | -0.36 +16.28% | -0.48 -20.00% | -0.34 -13.33% | -0.4 -29.03% | -0.13 +63.89% | -1.35 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.43 -- | -- -- | -0.3 -- | -0.31 -- | -0.36 +16.28% | -- -- | -0.34 -13.33% | -0.4 -29.03% | -0.13 +63.89% | -- -- |
Diluted EPS | -23.41 -- | -- -- | -31.53 -- | -228.29 -- | -36.88 -57.54% | -- -- | -0.6 +98.10% | -0.64 +99.72% | -0.54 +98.54% | -- -- | -0.59 +1.67% | -0.74 -15.62% | -0.43 +20.37% | -- -- | -0.3 +49.15% | -0.31 +58.11% | -0.36 +16.28% | -- -- | -0.34 -13.33% | -0.4 -29.03% | -0.13 +63.89% | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.43 -- | -- -- | -0.3 -- | -0.31 -- | -0.36 +16.28% | -- -- | -0.34 -13.33% | -0.4 -29.03% | -0.13 +63.89% | -- -- |
You can ask Aime
What is IO Biotech's gross profit margin?What is the market's earnings forecast for IO Biotech next quarter?What does IO Biotech do and what are its main business segments?What were the key takeaways from IO Biotech’s earnings call?What is the revenue and EPS growth rate for IO Biotech year over year?What is IO Biotech's latest dividend and current dividend yield?What factors drove the changes in IO Biotech's revenue and profit?What guidance did IO Biotech's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
